Dynamic Technology Lab Private Ltd raised its stake in shares of Aetna Inc. (NYSE:AET) by 72.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 5,874 shares of the company’s stock after purchasing an additional 2,474 shares during the period. Dynamic Technology Lab Private Ltd’s holdings in Aetna were worth $934,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in AET. Lloyds Banking Group plc bought a new position in shares of Aetna in the third quarter worth about $106,000. Bruderman Asset Management LLC bought a new position in shares of Aetna in the second quarter worth about $106,000. Moisand Fitzgerald Tamayo LLC bought a new position in shares of Aetna in the third quarter worth about $116,000. Liberty Capital Management Inc. boosted its stake in shares of Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after acquiring an additional 629 shares during the period. Finally, Westside Investment Management Inc. boosted its stake in shares of Aetna by 53.5% in the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock worth $177,000 after acquiring an additional 400 shares during the period. 88.03% of the stock is owned by institutional investors and hedge funds.
Shares of Aetna Inc. (AET) traded down $0.07 during mid-day trading on Thursday, reaching $178.83. The company’s stock had a trading volume of 4,485,753 shares, compared to its average volume of 2,588,375. Aetna Inc. has a fifty-two week low of $116.04 and a fifty-two week high of $192.37. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53. The stock has a market capitalization of $58,283.73, a P/E ratio of 17.50, a PEG ratio of 1.63 and a beta of 0.61.
Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The business had revenue of $14.99 billion for the quarter, compared to the consensus estimate of $15.12 billion. During the same period in the prior year, the business posted $2.07 earnings per share. The company’s quarterly revenue was down 5.0% compared to the same quarter last year. equities research analysts expect that Aetna Inc. will post 9.78 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Thursday, January 11th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a yield of 1.12%. Aetna’s dividend payout ratio (DPR) is presently 37.04%.
In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now directly owns 33,563 shares in the company, valued at $5,465,734.55. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the sale, the president now owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
A number of equities analysts have recently weighed in on the company. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $175.00 price objective on shares of Aetna in a research note on Monday, October 23rd. Citigroup upped their price objective on Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a research note on Thursday, November 2nd. BMO Capital Markets upped their price objective on Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research note on Friday, October 27th. Zacks Investment Research lowered Aetna from a “buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. Finally, Argus reiterated a “buy” rating and issued a $185.00 target price (up from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Twelve investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $175.19.
TRADEMARK VIOLATION WARNING: This article was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2017/12/07/dynamic-technology-lab-private-ltd-has-934000-stake-in-aetna-inc-aet.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.